<DOC>
	<DOC>NCT01191086</DOC>
	<brief_summary>The purpose of this study is to examine the safety of USL255 as adjunctive therapy in patients with refractory partial onset-seizures.</brief_summary>
	<brief_title>Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Have completed the maintenance period of the P09004 study. Continue to be treated with a stable dose of 1 to a maximum of 3 approved concomitant AEDs.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>partial onset seizure</keyword>
	<keyword>adjunctive therapy</keyword>
</DOC>